For the second successive year, the Multiple Sclerosis Society of WA (MSWA) is delighted to have been able to contribute more than $1 million towards research to help find the cause and cure for MS.
One of the research projects predominantly funded by MSWA includes providing $1.5 million over a 2 year period, towards the international PrevANZ Vitamin D Prevention Trial, some of which is being conducted here in Western Australia.
This is a world first, clinical trial that will test whether vitamin D supplements can prevent MS in those at risk of developing the condition. There is a significant amount of evidence about the role that vitamin D deficiency plays in MS, but there hasn’t been a clinical trial conducted on what the benefits of vitamin D supplements might be, or what the correct dosage should be.
"We look forward to seeing the results of this study, and hope that it will provide answers for people living with MS," said MSWA CEO, Marcus Stafford.